These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24428524)

  • 1. Antihypertensive drugs and the risk of incident rosacea.
    Spoendlin J; Voegel JJ; Jick SS; Meier CR
    Br J Dermatol; 2014 Jul; 171(1):130-6. PubMed ID: 24428524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between beta-blockers, other antihypertensive drugs and psoriasis: population-based case-control study.
    Brauchli YB; Jick SS; Curtin F; Meier CR
    Br J Dermatol; 2008 Jun; 158(6):1299-307. PubMed ID: 18410416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of antihypertensives and the risk of Parkinson disease.
    Becker C; Jick SS; Meier CR
    Neurology; 2008 Apr; 70(16 Pt 2):1438-44. PubMed ID: 18256367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study.
    Schaer BA; Schneider C; Jick SS; Conen D; Osswald S; Meier CR
    Ann Intern Med; 2010 Jan; 152(2):78-84. PubMed ID: 20083826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive medications and risk of community-acquired pneumonia.
    Mukamal KJ; Ghimire S; Pandey R; O'Meara ES; Gautam S
    J Hypertens; 2010 Feb; 28(2):401-5. PubMed ID: 20051911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Angiotensin-Converting Enzyme Inhibitor and β-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the U.K. Clinical Practice Research Datalink.
    Hagberg KW; Sahasrabuddhe VV; McGlynn KA; Jick SS
    Pharmacotherapy; 2016 Feb; 36(2):187-95. PubMed ID: 26846893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive medication use is associated with increased organ system involvement and hospitalization in emergency department patients with anaphylaxis.
    Lee S; Hess EP; Nestler DM; Bellamkonda Athmaram VR; Bellolio MF; Decker WW; Li JT; Hagan JB; Manivannan V; Vukov SC; Campbell RL
    J Allergy Clin Immunol; 2013 Apr; 131(4):1103-8. PubMed ID: 23453138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study.
    Rejnmark L; Vestergaard P; Mosekilde L
    J Hypertens; 2006 Mar; 24(3):581-9. PubMed ID: 16467662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term use of antihypertensive drugs and risk of cancer.
    Assimes TL; Elstein E; Langleben A; Suissa S
    Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1039-49. PubMed ID: 18780400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial non-compliance with antihypertensive monotherapy is followed by complete discontinuation of antihypertensive therapy.
    Van Wijk BL; Klungel OH; Heerdink ER; de Boer A
    Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):587-93. PubMed ID: 16586465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of beta-blockers and risk of fractures.
    Schlienger RG; Kraenzlin ME; Jick SS; Meier CR
    JAMA; 2004 Sep; 292(11):1326-32. PubMed ID: 15367554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and the risk of developing rheumatoid arthritis in antihypertensive drug users.
    de Jong HJ; Vandebriel RJ; Saldi SR; van Dijk L; van Loveren H; Cohen Tervaert JW; Klungel OH
    Pharmacoepidemiol Drug Saf; 2012 Aug; 21(8):835-43. PubMed ID: 22674737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive persistence and drug class.
    Marentette MA; Gerth WC; Billings DK; Zarnke KB
    Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive Use and the Risk of Cataract in Patients with Hypertension: A Nationwide Case-control Study.
    Yang HL; Byun SJ; Park S; Lee SH; Park SJ; Jung SY
    Ophthalmic Epidemiol; 2023 Oct; 30(5):499-508. PubMed ID: 36369827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Skin diseases caused by antihypertensive agents].
    Watabe Y
    Nihon Rinsho; 1992 May; 50 Suppl():125-30. PubMed ID: 1355122
    [No Abstract]   [Full Text] [Related]  

  • 16. Calcium-channel blockers and risk of cancer.
    Jick H; Jick S; Derby LE; Vasilakis C; Myers MW; Meier CR
    Lancet; 1997 Feb; 349(9051):525-8. PubMed ID: 9048789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Change from ACE inhibitor, Ca-antagonist or beta-blocker to candesartan cilexetil: better efficacy and tolerance. SWITCH study (German study segment)].
    Baumgart P; Reismann J; Pohlmeyer H; Düsing R
    Dtsch Med Wochenschr; 2001 May; 126(19):547-50. PubMed ID: 11402910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.
    Gress TW; Nieto FJ; Shahar E; Wofford MR; Brancati FL
    N Engl J Med; 2000 Mar; 342(13):905-12. PubMed ID: 10738048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive agents and the risk of breast cancer in women aged 55 years and older: a nested case-control study.
    Chang CH; Chiang CH; Yen CJ; Wu LC; Lin JW; Lai MS
    J Hypertens; 2016 Mar; 34(3):558-66; discussion 566. PubMed ID: 26818924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between psychiatric diseases, psychotropic drugs and the risk of incident rosacea.
    Spoendlin J; Bichsel F; Voegel JJ; Jick SS; Meier CR
    Br J Dermatol; 2014 Apr; 170(4):878-83. PubMed ID: 24236423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.